Private Wealth Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Private Wealth Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$179K	Sell	401 -1	-0.2%	-$466	0.02%	271
2025 Q4	$182K	Hold	402	–	–	0.02%	270
2025 Q3	$157K	Sell	402 -85	-17%	-$35.5K	0.02%	264
2025 Q2	$217K	Buy	487 +9	+2%	+$4.15K	0.03%	229
2025 Q1	$232K	Buy	+478	New	+$223K	0.03%	210

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Private Wealth Asset Management's VRTX Position: Q1 2026 in Review

Private Wealth Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 0.25% in Q1 2026, selling an estimated $466 and leaving 401 shares worth $179K. The position accounts for 0.02% of the portfolio, ranked #271.

Private Wealth Asset Management first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $232K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Private Wealth Asset Management held 401 shares of Vertex Pharmaceuticals worth $179K as of Q1 2026.
Private Wealth Asset Management sold 1 Vertex Pharmaceuticals share in Q1 2026, an estimated $466.
Vertex Pharmaceuticals made up 0.02% of Private Wealth Asset Management's portfolio in Q1 2026, its #271 holding.
Private Wealth Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
Private Wealth Asset Management's Vertex Pharmaceuticals position peaked at $232K in Q1 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Private Wealth Asset Management's 13F filing for Q1 2026, filed 6 May 2026.